/Investor DB

Neomed Management

Late Stage

Find your way into Neomed Management

✨ Fox Verdict
Sign up to see your fit
Stage
Late Stage
Tracked investments
1
Acquisitions
1

What they invest in

from 1 of 1 portfolio companies

Biotech ×1Hardware ×1Medical Devices ×1

HQs:United States×1

Investments · 1 tracked

founders shown can be your intro path
Avitideavitide.comJun 2017acquired by Repligen

Repligen provides bioprocessing technologies—including process intensification, tangential flow filtration, chromatography, process analytics, and single-use fluid management—for upstream and downstream biopharmaceutical workflows.

BiotechHardwareMedical DevicesLebanon, US

Tillman Gerngross(Director)Errik Anderson(Director)inWarren Kett(Executive Officer)Jon Sheller(Executive Officer)Kevin Issett(Executive Officer, Director)Kevin Isett(Executive Officer, Director)

Co-investorsOrbiMedSV Health InvestorsBorealis VenturesMithril Capital ManagementPolaris PartnersSands Capital Ventures+1 more

Exits · 1

1 acquisitions

Avitideacq. by Repligen

Frequently asked questions

What stage does Neomed Management invest at?
Neomed Management invests at the Late Stage stage.

Similar investors

Featured in lists